Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Non-Current Debt (2016 - 2021)

Historic Non-Current Debt for Arcadia Biosciences (RKDA) over the last 7 years, with Q3 2021 value amounting to $78000.0.

  • Arcadia Biosciences' Non-Current Debt fell 9693.88% to $78000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $78000.0, marking a year-over-year decrease of 9693.88%. This contributed to the annual value of $2.1 million for FY2020, which is 186728.97% up from last year.
  • As of Q3 2021, Arcadia Biosciences' Non-Current Debt stood at $78000.0, which was down 9693.88% from $87000.0 recorded in Q2 2021.
  • Arcadia Biosciences' Non-Current Debt's 5-year high stood at $23.1 million during Q1 2017, with a 5-year trough of $78000.0 in Q3 2021.
  • Its 4-year average for Non-Current Debt is $4.7 million, with a median of $130000.0 in 2020.
  • Per our database at Business Quant, Arcadia Biosciences' Non-Current Debt surged by 215486.73% in 2020 and then plummeted by 9693.88% in 2021.
  • Over the past 4 years, Arcadia Biosciences' Non-Current Debt (Quarter) stood at $21.1 million in 2017, then crashed by 99.49% to $107000.0 in 2019, then skyrocketed by 1867.29% to $2.1 million in 2020, then plummeted by 96.29% to $78000.0 in 2021.
  • Its Non-Current Debt stands at $78000.0 for Q3 2021, versus $87000.0 for Q2 2021 and $96000.0 for Q1 2021.